Skip to content

ACToR-study : Angiographic CT of Renal Transplantation Candidate - Study

Angiographic CT of Renal Transplantation Candidate - Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01344434
Acronym
ACToR
Enrollment
167
Registered
2011-04-29
Start date
2011-02-28
Completion date
2014-02-28
Last updated
2014-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Transplant Candidate for Left Kidney, Renal Transplant Candidate for Right Kidney

Brief summary

This study hypothesizes that renal transplantation candidates are diagnosed with significant Coronary Artery Disease (CAD) equal with non-invasive modalities as with invasive modalities. Therefore the investigators are investigating the ability of coronary computed tomographic angiography (cCTA), myocardial perfusion scintigraphy (MPS), acoustic CAD Patch and combination hereof to detect CAD as defined by invasive Coronary angiography (CAG).

Detailed description

Chronic kidney disease is a known risk factor for cardiovascular disease and cardiovascular disease is the leading cause of mortality in end-stage renal disease (ESRD) patients. After renal transplantation one-half of all deaths are cardiac, usually in the first 5 years in the presence of a functional graft. Because of this renal transplantation candidates are undergoing cardiac pre-transplant risk stratification. There is no consensus regarding which modality should be use for detection of CAD in this cardiac pre-transplant risk stratification. CAG is known as gold standard but is a invasive procedure with risk of complication. The investigators wish to investigate the ability of detecting CAD as defined by invasive Coronary angiography (CAG) by clinical examination, blood test and non-invasive test (cCTA, MPS and acoustic CAD Patch). The investigators hypothesize that a single modality or combination of these with high sensitivity and specificity could diagnose significant CAD without the need of further invasive procedures. This study will include 150 renal transplantations candidate.

Interventions

None listed

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Endstage renal disease * Preparing for renal transplantation * Indication for CAG

Exclusion criteria

* Known allergy to iodinated contrast * Women who are pregnant or nursing * Severe mental illness

Design outcomes

Primary

MeasureTime frameDescription
To investigate the ability of non-invasive tests to detect CAD as defined by invasive angiography in renal transplantation candidates.2013 octoberBaseline results of coronary computed tomographic angiography (cCTA), myocardial perfusion scintigraphy (MPS), acoustic CAD Patch and combination hereof to detect CAD as defined by invasive Coronary angiography (CAG).

Secondary

MeasureTime frameDescription
To investigate the risk of Contrast-Induced Nephropathy (CIN) after cCTA and CAG.2013 octoberBlood sample of creatinine after contrast exposure.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026